Lazard Asset Management LLC Amphastar Pharmaceuticals, Inc. Transaction History
Lazard Asset Management LLC
- $82.4 Billion
- Q1 2024
A detailed history of Lazard Asset Management LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 9,017 shares of AMPH stock, worth $347,695. This represents 0.0% of its overall portfolio holdings.
Number of Shares
9,017
Previous 9,197
1.96%
Holding current value
$347,695
Previous $568,000
30.46%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding AMPH
# of Institutions
276Shares Held
33.4MCall Options Held
56.6KPut Options Held
57.3K-
Black Rock Inc. New York, NY6.08MShares$234 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$105 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA2.08MShares$80.1 Million0.21% of portfolio
-
Neuberger Berman Group LLC New York, NY1.66MShares$64 Million0.06% of portfolio
-
State Street Corp Boston, MA1.51MShares$58.4 Million0.0% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $1.89B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...